Date published: 2025-10-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

cyclin T1 Inhibitors

Common cyclin T1 Inhibitors include, but are not limited to Flavopiridol CAS 146426-40-6, Roscovitine CAS 186692-46-6, Dinaciclib CAS 779353-01-4, AT7519 CAS 844442-38-2 and SNS-032 CAS 345627-80-7.

Cyclin T1 inhibitors are a class of chemical compounds designed to target and modulate the activity of cyclin T1, a protein that plays a crucial role in the regulation of transcription processes. Cyclin T1 is a component of the positive transcription elongation factor b (P-TEFb) complex, which is essential for facilitating the transition of RNA polymerase II from transcription initiation to elongation. This transition is a pivotal step in gene expression regulation, as it determines the rate of transcription and ultimately influences the synthesis of proteins involved in various cellular functions.

The inhibitors within this class are developed with a specific focus on disrupting the interactions and activities of cyclin T1, altering the transcriptional elongation process. By selectively targeting cyclin T1, these compounds provide researchers with a valuable tool to investigate the intricate mechanisms of transcription regulation and its impact on cellular processes. The study of cyclin T1 inhibitors offers insights into the complex interplay between transcription factors, co-factors, and RNA polymerase, contributing to a better understanding of gene expression control and its relevance in various biological contexts.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Flavopiridol

146426-40-6sc-202157
sc-202157A
5 mg
25 mg
$78.00
$254.00
41
(3)

CDK inhibitor targeting Cyclin T1-dependent kinase CDK9, disrupting transcription elongation by inhibiting RNA Pol II.

Roscovitine

186692-46-6sc-24002
sc-24002A
1 mg
5 mg
$92.00
$260.00
42
(2)

Competes with ATP for CDK9 binding, leading to transcriptional inhibition by RNA Pol II.

Dinaciclib

779353-01-4sc-364483
sc-364483A
5 mg
25 mg
$242.00
$871.00
1
(0)

Binds to CDK9's ATP-binding pocket, inhibiting kinase activity and RNA Pol II phosphorylation.

AT7519

844442-38-2sc-364416
sc-364416A
sc-364416B
sc-364416C
5 mg
10 mg
100 mg
1 g
$207.00
$246.00
$1025.00
$3065.00
1
(0)

Impairs CDK9 kinase activity, resulting in RNA Pol II dephosphorylation and transcriptional suppression.

SNS-032

345627-80-7sc-364621
sc-364621A
5 mg
10 mg
$169.00
$262.00
(1)

Selective CDK9 inhibitor, binding to ATP site and hindering CDK9's ability to phosphorylate RNA Pol II.